BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 24617316)

  • 1. Is there any association between where patients spend the end of life and survival after anticancer treatment for gynecologic malignancy?
    Kajiyama H; Utsumi F; Higashi M; Sakata J; Sekiya R; Mizuno M; Umezu T; Suzuki S; Yamamoto E; Mitsui H; Niimi K; Shibata K; Kikkawa F
    J Palliat Med; 2014 Mar; 17(3):325-30. PubMed ID: 24617316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after Anticancer Treatment of Terminally Ill Patients with Ovarian Carcinoma.
    Kajiyama H; Suzuki S; Shimbo A; Utsumi F; Yoshikawa N; Kikkawa F
    J Palliat Med; 2020 Aug; 23(8):1060-1065. PubMed ID: 32293976
    [No Abstract]   [Full Text] [Related]  

  • 3. The utilization of palliative care in gynecologic oncology patients near the end of life.
    Fauci J; Schneider K; Walters C; Boone J; Whitworth J; Killian E; Straughn JM
    Gynecol Oncol; 2012 Oct; 127(1):175-9. PubMed ID: 22735789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of familial factors on the choice of the place of death for terminally ill breast cancer patients: a retrospective single-center study.
    Harano K; Yonemori K; Hirakawa A; Shimizu C; Katsumata N; Gemma A; Fujiwara Y; Tamura K
    Breast Cancer; 2016 Sep; 23(5):797-806. PubMed ID: 26439379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Too much, too late: Aggressive measures and the timing of end of life care discussions in women with gynecologic malignancies.
    Zakhour M; LaBrant L; Rimel BJ; Walsh CS; Li AJ; Karlan BY; Cass I
    Gynecol Oncol; 2015 Aug; 138(2):383-7. PubMed ID: 26049124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of palliative care services on the aggressiveness of end-of-life care in the Veteran's Affairs cancer population.
    Gonsalves WI; Tashi T; Krishnamurthy J; Davies T; Ortman S; Thota R; Aldoss I; Ganta A; Kalaiah M; Didwaniya N; Eberle C; Ganti AK; Silberstein PT; Subbiah S
    J Palliat Med; 2011 Nov; 14(11):1231-5. PubMed ID: 21877925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
    von Tempelhoff GF; Nieman F; Heilmann L; Hommel G
    Clin Hemorheol Microcirc; 2000; 22(2):107-30. PubMed ID: 10831062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
    Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
    Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between early palliative care referrals, inpatient hospice utilization, and aggressiveness of care at the end of life.
    Amano K; Morita T; Tatara R; Katayama H; Uno T; Takagi I
    J Palliat Med; 2015 Mar; 18(3):270-3. PubMed ID: 25210851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resource utilization for ovarian cancer patients at the end of life: how much is too much?
    Lewin SN; Buttin BM; Powell MA; Gibb RK; Rader JS; Mutch DG; Herzog TJ
    Gynecol Oncol; 2005 Nov; 99(2):261-6. PubMed ID: 16140364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Place of Death Among Patients With Gynecologic Cancer in the United States.
    Hicks-Courant K; Melamed A; Worley MJ; Kim YB; Schorge JO; Rauh-Hain JA
    Obstet Gynecol; 2018 Jun; 131(6):1111-1120. PubMed ID: 29742673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modest benefit of total parenteral nutrition and chemotherapy after venting gastrostomy tube placement.
    Diver E; O'Connor O; Garrett L; Boruta D; Goodman A; Del Carmen M; Schorge J; Mueller P; Growdon W
    Gynecol Oncol; 2013 May; 129(2):332-5. PubMed ID: 23402902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Prognostic Study of Death at Home or Hospice Versus at a Hospital Among Patients With Advanced Non-Small Cell Lung Cancer.
    Hamamoto Y; Ibe T; Kodama H; Mouri A; Mineshita M
    Am J Hosp Palliat Care; 2020 Feb; 37(2):129-135. PubMed ID: 31366208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. End of life care for women with gynecologic cancers.
    Barbera L; Elit L; Krzyzanowska M; Saskin R; Bierman AS
    Gynecol Oncol; 2010 Aug; 118(2):196-201. PubMed ID: 20466411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer.
    Lopez-Acevedo M; Havrilesky LJ; Broadwater G; Kamal AH; Abernethy AP; Berchuck A; Alvarez Secord A; Tulsky JA; Valea F; Lee PS
    Gynecol Oncol; 2013 Jul; 130(1):156-61. PubMed ID: 23587882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient end of life discussions shorten hospital admissions in gynecologic oncology patients.
    Doll KM; Stine JE; Van Le L; Moore DT; Bae-Jump V; Brewster WR; Soper JT; Boggess JF; Gehrig PA; Kim KH
    Gynecol Oncol; 2013 Jul; 130(1):152-5. PubMed ID: 23542684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid use at the end of life and survival in a Hospital at Home unit.
    Bengoechea I; Gutiérrez SG; Vrotsou K; Onaindia MJ; Lopez JM
    J Palliat Med; 2010 Sep; 13(9):1079-83. PubMed ID: 20799903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends among gynecologic oncology inpatient deaths: is end-of-life care improving?
    Dalrymple JL; Levenback C; Wolf JK; Bodurka DC; Garcia M; Gershenson DM
    Gynecol Oncol; 2002 May; 85(2):356-61. PubMed ID: 11972400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inpatient versus outpatient management of neutropenic fever in gynecologic oncology patients: is risk stratification useful?
    Gunderson CC; Farrell R; Dinh BC; Thomas ED; Vesely SK; Lauer JK; Kao L; Chopra S; McMeekin DS; Moore KN
    Gynecol Oncol; 2013 Sep; 130(3):411-5. PubMed ID: 23791827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO.
    Pfisterer J; Weber B; Reuss A; Kimmig R; du Bois A; Wagner U; Bourgeois H; Meier W; Costa S; Blohmer JU; Lortholary A; Olbricht S; Stähle A; Jackisch C; Hardy-Bessard AC; Möbus V; Quaas J; Richter B; Schröder W; Geay JF; Lück HJ; Kuhn W; Meden H; Nitz U; Pujade-Lauraine E; ;
    J Natl Cancer Inst; 2006 Aug; 98(15):1036-45. PubMed ID: 16882940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.